发明名称 |
Biomarkers For Diagnosis Of Diabetes And Monitoring Of Anti-Diabetic Therapy |
摘要 |
The present invention relates to the use of N-linked glycan profiles of blood or blood component proteins as biomarkers for diagnosing diabetes mellitus and for monitoring the efficacy of anti-diabetic therapy. Specifically, the present invention relates to detecting changes in the amounts of N-linked glycans as diagnostic biomarkers for diabetes mellitus and as indicators of the efficacy of anti-diabetic therapy over time. |
申请公布号 |
US2015204881(A1) |
申请公布日期 |
2015.07.23 |
申请号 |
US201314395132 |
申请日期 |
2013.04.19 |
申请人 |
Sumitomo Bakelite Co., Ltd. |
发明人 |
Asada Hidehisa;Mccarthy Diane;Miura Yoshiaki;Nakahara Taku |
分类号 |
G01N33/66;G01N27/447 |
主分类号 |
G01N33/66 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of monitoring a level of glycemic control in a subject during anti-diabetic therapy or treatment comprising:
(a) providing an N-glycan composition of a blood or blood component sample obtained from the subject at a first time-point during the anti-diabetic therapy or treatment; and (b) determining an N-glycan composition of a blood or blood component sample obtained from the subject at a second time-point during the anti-diabetic therapy or treatment, wherein the second time-point is subsequent to the first time-point, wherein a difference between the N-glycan composition of the sample at the second time-point and the N-glycan composition of the sample at the first time-point indicates an increased or decreased level of glycemic control at the second time-point compared to the first time-point. |
地址 |
Tokyo JP |